The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome. (Q53430061)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

D Bowen

11

0 references

author name string

A K Burnett

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

A Hunter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

D Milligan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Kell

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

K Wheatley

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Yin

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

M-F McMullin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

P Cahalin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

J Craig

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

N Russell

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

8 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1122-1127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2011.59

27 January 2020

exact match

0 references

cites work

Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Phase II trial of arsenic trioxide in relapsed and refractory acute myeloid leukemia, secondary leukemia and/or newly diagnosed patients at least 65 years old.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2011.59

The outcomes and costs of acute myeloid leukemia among the elderly

21 January 2018

1 reference

12 December 2020

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival

1 reference

12 December 2020

The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia

1 reference

12 December 2020

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2011.59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21475252%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference